Your browser doesn't support javascript.
loading
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern.
Berger, Gerbrig; Gerritsen, Mylene; Yi, Guoqiang; Koorenhof-Scheele, Theresia N; Kroeze, Leonie I; Stevens-Kroef, Marian; Yoshida, Kenichi; Shiraishi, Yuichi; van den Berg, Eva; Schepers, Hein; Huls, Geert; Mulder, André B; Ogawa, Seishi; Martens, Joost H A; Jansen, Joop H; Vellenga, Edo.
Afiliação
  • Berger G; Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Gerritsen M; Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Yi G; Department of Molecular Biology, Radboud University, Nijmegen, The Netherlands.
  • Koorenhof-Scheele TN; Laboratory of Hematology and.
  • Kroeze LI; Laboratory of Hematology and.
  • Stevens-Kroef M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Yoshida K; Department of Pathology & Tumor Biology, Kyoto University, Kyoto, Japan.
  • Shiraishi Y; Laboratory of DNA information Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • van den Berg E; Department of Genetics and.
  • Schepers H; Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Huls G; Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Mulder AB; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Ogawa S; Department of Pathology & Tumor Biology, Kyoto University, Kyoto, Japan.
  • Martens JHA; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan; and.
  • Jansen JH; Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinksa Institute, Stockholm, Sweden.
  • Vellenga E; Department of Molecular Biology, Radboud University, Nijmegen, The Netherlands.
Blood Adv ; 3(20): 3111-3122, 2019 10 22.
Article em En | MEDLINE | ID: mdl-31648334
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Regulação Leucêmica da Expressão Gênica / Eritroblastos / Transcriptoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Regulação Leucêmica da Expressão Gênica / Eritroblastos / Transcriptoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda